Target Trial Emulation: A Practical Introduction for Hepatology Research
Clinical and Molecular Hepatology · 17.11.2026
DOI: 10.3350/cmh.2026.0774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 17.11.2026. Verfasst von Yeonjin Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
Abstract (Originalsprache)
Randomized controlled trials (RCTs) are considered the gold standard for causal inference; however, in hepatology research, their feasibility is often limited by ethical constraints, long disease trajectories, and complex treatment decisions. As a result, real-world data (RWD) are increasingly used, but conventional observational analyses remain vulnerable to biases such as immortal time bias, confounding, and misalignment between clinical questions and study design. Target trial emulation (TTE) addresses these limitations by explicitly defining a hypothetical randomized trial and emulating it using observational data. TTE can estimate clinically relevant causal estimands, including observational analogues of the intention-to-treat (ITT) and per-protocol effects, by explicitly defining treatment strategies and follow-up procedures. This paper provides a practical guide to the application of TTE in hepatology research, focusing on key principles of causal inference design using the TTE framework. Using the HEROES study as an illustrative example, we show how target trial components-eligibility criteria, treatment strategies, assignment, follow-up, outcomes, and estimand-can be explicitly specified from clinical questions. We describe the sequential trial emulation (STE) approach, in which a single observational cohort is reformulated into a series of risk-set-based hypothetical trials over time to address time-varying treatment initiation, and the cloning-censoring-weighting (CCW) approach, which enables the emulation of dynamic treatment strategies in observational data. Overall, this paper emphasizes the importance of aligning clinical questions with the causal estimand and improving the transparency and validity of real-world evidence in hepatology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea. lwj221@snu.ac.kr.
Zitieren
APA
Kim, Y., Jang, H., & Lee, W. (2026). Target Trial Emulation: A Practical Introduction for Hepatology Research. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0774
Vancouver
Kim Y, Jang H, Lee W. Target Trial Emulation: A Practical Introduction for Hepatology Research. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0774
BibTeX
@article{Kim2026,
author = {Kim, Yeonjin and Jang, Heejoon and Lee, Woojoo},
title = {Target Trial Emulation: A Practical Introduction for Hepatology Research},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0774}
}
EUVIMED